BRITTANY ZILLER: Open Payments
NPI 1528722089 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 41 payments from 13 companies in 2025. Trend: 2023 $257 · 2024 $539 · 2025 $813
Food & beverage: $780Education: $32
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $187 |
| Mayne Pharma Commercial LLC | 6 | $131 |
| Biogen, Inc. | 5 | $92 |
| ABBVIE INC. | 3 | $73 |
| Exact Sciences Corporation | 3 | $71 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $63 |
| Novo Nordisk Inc | 2 | $53 |
| Astellas Pharma US Inc | 2 | $30 |
| Lilly USA, LLC | 1 | $25 |
| Organon LLC | 1 | $25 |
Products named: GEMTESA, ZURZUVAE, MYFEMBREE, JOURNAVX, UBRELVY, Wegovy, Cologuard Collection Kit, Veozah.
Industry payments across IL — which companies pay providers there.
